<p>Curaleaf Holdings, Inc. (OTCMKTS:CURLF - 獲取免費報告) 在週一市場開盤前出現了下跌缺口。該股票之前收於 $2.37，但開盤價為 $2.21。Curaleaf 的股票最後交易價格為 $2.25，成交量為 45,165 股。</p>
<h2>分析師設定新的價格目標</h2>
<ul>
<li>大麻股票反彈的機會：幻想還是機會？</li>
</ul>
<p>幾位股票研究分析師最近對該股票發表了評論。Zacks Research 在 1 月 1 日的研究報告中將 Curaleaf 的評級從 “強烈賣出” 上調至 “持有”。ATB Cormark Capital Markets 在 12 月 2 日的研究報告中將 Curaleaf 的評級上調至 “跑贏大盤”。最後，Alliance Global Partners 在 12 月 22 日的報告中重新發布了對 Curaleaf 的 “買入” 評級。兩位分析師給予該股票 “強烈買入” 評級，一位給予 “買入” 評級，一位給予 “持有” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “買入”。</p>
<p><strong>查看我們關於 Curaleaf 的最新報告</strong></p>
<h2>Curaleaf 股價下跌 4.2%</h2>
<ul>
<li>三隻準備蓬勃發展的大麻股票</li>
</ul>
<p>該公司的債務與股本比率為 1.14，速動比率為 0.76，流動比率為 1.52。該公司的 50 日簡單移動平均線為 $2.45，200 日簡單移動平均線為 $2.68。該公司的市值為 15.4 億美元，市盈率為 -7.57，貝塔係數為 0.71。</p>
<p>Curaleaf (OTCMKTS:CURLF - 獲取免費報告) 最近在 2 月 26 日發佈了季度財報。該公司報告每股收益（EPS）為 ($0.05)，超出分析師共識預期的 ($0.08) 0.03 美元。該公司季度收入為 3.3307 億美元，而共識預期為 3.2870 億美元。Curaleaf 的淨利潤率為 -18.08%，股本回報率為 -23.17%。股票研究分析師預測 Curaleaf Holdings, Inc. 今年的每股收益將為 -0.25。</p>
<h2>Curaleaf 公司簡介</h2>
<p>(獲取免費報告)</p>
<ul>
<li>SAFE 法案能否點燃大麻行業的高期望？</li>
</ul>
<p>Curaleaf Holdings, Inc 是一家領先的美國大麻公司，專注於醫療和成人使用大麻產品的種植、加工和分銷。公司總部位於馬薩諸塞州的韋克菲爾德，Curaleaf 在多個美國司法管轄區運營種植設施、加工中心和零售藥房。公司的垂直整合模式使其能夠管理整個供應鏈，從種子到銷售，確保一致的質量和符合嚴格的監管要求。</p>
<p>Curaleaf 的產品組合涵蓋多種形式，包括優質花朵、蒸汽煙霧器、食用產品、酊劑、外用藥和濃縮物。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過 Curaleaf</li>
<li>華爾街害怕的黃金圖表……</li>
<li>美國的 1776 再次發生</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
<li>埃隆·馬斯克已經讓我成為 “富有的人”</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Curaleaf 嗎？</h2>
<p>在你考慮投資 Curaleaf 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Curaleaf 並不在名單上。</p>
<p>雖然 Curaleaf 目前在分析師中獲得了 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CURLF

<p>Curaleaf Holdings, Inc.（OTCMKTS:CURLF）股價從 2.37 美元跳空下跌至 2.21 美元，隨後交易於 2.25 美元。分析師的評級不一，Zacks 將評級上調至 “持有”，而 ATB Cormark 則上調至 “跑贏大盤”。Curaleaf 報告的季度每股收益為（0.05 美元），超出預期，收入為 3.3307 億美元。該公司的市值為 15.4 億美元，淨利潤率為負 18.08%。儘管當前的共識為 “買入”，但一些分析師建議存在更好的投資機會</p>

<p>Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $2.37, but opened at $2.21. Curaleaf shares last traded at $2.25, with a volume of 45,165 shares changing hands.</p>
<div class="lb-trans"><p>Curaleaf Holdings, Inc. (OTCMKTS:CURLF - 獲取免費報告) 在週一市場開盤前出現了下跌缺口。該股票之前收於 $2.37，但開盤價為 $2.21。Curaleaf 的股票最後交易價格為 $2.25，成交量為 45,165 股。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新的價格目標</h2>
</div><ul>
<li>Cannabis Stocks Up for Reversal: Pipedreams or Opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻股票反彈的機會：幻想還是機會？</li>
</ul>
</div><p>Several equities research analysts have recently commented on the stock. Zacks Research raised shares of Curaleaf from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, January 1st. ATB Cormark Capital Markets raised shares of Curaleaf to an &#34;outperform&#34; rating in a research report on Tuesday, December 2nd. Finally, Alliance Global Partners reissued a &#34;buy&#34; rating on shares of Curaleaf in a report on Monday, December 22nd. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對該股票發表了評論。Zacks Research 在 1 月 1 日的研究報告中將 Curaleaf 的評級從 “強烈賣出” 上調至 “持有”。ATB Cormark Capital Markets 在 12 月 2 日的研究報告中將 Curaleaf 的評級上調至 “跑贏大盤”。最後，Alliance Global Partners 在 12 月 22 日的報告中重新發布了對 Curaleaf 的 “買入” 評級。兩位分析師給予該股票 “強烈買入” 評級，一位給予 “買入” 評級，一位給予 “持有” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “買入”。</p>
</div><p><strong>View Our Latest Report on Curaleaf</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Curaleaf 的最新報告</strong></p>
</div><h2>Curaleaf Trading Down 4.2%</h2>
<div class="lb-trans"><h2>Curaleaf 股價下跌 4.2%</h2>
</div><ul>
<li>3 Growing Cannabis Stocks Ready To Bloom</li>
</ul>
<div class="lb-trans"><ul>
<li>三隻準備蓬勃發展的大麻股票</li>
</ul>
</div><p>The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.76 and a current ratio of 1.52. The firm has a 50 day simple moving average of $2.45 and a two-hundred day simple moving average of $2.68. The firm has a market capitalization of $1.54 billion, a P/E ratio of -7.57 and a beta of 0.71.</p>
<div class="lb-trans"><p>該公司的債務與股本比率為 1.14，速動比率為 0.76，流動比率為 1.52。該公司的 50 日簡單移動平均線為 $2.45，200 日簡單移動平均線為 $2.68。該公司的市值為 15.4 億美元，市盈率為 -7.57，貝塔係數為 0.71。</p>
</div><p>Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The firm had revenue of $333.07 million for the quarter, compared to the consensus estimate of $328.70 million. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%. Equities research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.</p>
<div class="lb-trans"><p>Curaleaf (OTCMKTS:CURLF - 獲取免費報告) 最近在 2 月 26 日發佈了季度財報。該公司報告每股收益（EPS）為 ($0.05)，超出分析師共識預期的 ($0.08) 0.03 美元。該公司季度收入為 3.3307 億美元，而共識預期為 3.2870 億美元。Curaleaf 的淨利潤率為 -18.08%，股本回報率為 -23.17%。股票研究分析師預測 Curaleaf Holdings, Inc. 今年的每股收益將為 -0.25。</p>
</div><h2>Curaleaf Company Profile</h2>
<div class="lb-trans"><h2>Curaleaf 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><ul>
<li>Can The SAFE Act Light Up High Hopes For Cannabis Industry?</li>
</ul>
<div class="lb-trans"><ul>
<li>SAFE 法案能否點燃大麻行業的高期望？</li>
</ul>
</div><p>Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company's vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.</p>
<div class="lb-trans"><p>Curaleaf Holdings, Inc 是一家領先的美國大麻公司，專注於醫療和成人使用大麻產品的種植、加工和分銷。公司總部位於馬薩諸塞州的韋克菲爾德，Curaleaf 在多個美國司法管轄區運營種植設施、加工中心和零售藥房。公司的垂直整合模式使其能夠管理整個供應鏈，從種子到銷售，確保一致的質量和符合嚴格的監管要求。</p>
</div><p>Curaleaf's product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.</p>
<div class="lb-trans"><p>Curaleaf 的產品組合涵蓋多種形式，包括優質花朵、蒸汽煙霧器、食用產品、酊劑、外用藥和濃縮物。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Curaleaf</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>Elon Musk already made me a “wealthy man”</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Curaleaf</li>
<li>華爾街害怕的黃金圖表……</li>
<li>美國的 1776 再次發生</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
<li>埃隆·馬斯克已經讓我成為 “富有的人”</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Curaleaf Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Curaleaf 嗎？</h2>
</div><p>Before you consider Curaleaf, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮投資 Curaleaf 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Curaleaf 並不在名單上。</p>
</div><p>While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Curaleaf 目前在分析師中獲得了 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Curaleaf (OTCMKTS:CURLF) 股價跳空下跌 - 接下來會如何發展？